Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Bortezomib
(D03150)		[2] Bortezomib,
Bortezomib D-mannitol		[1] Bortezomib (D03150) 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[16] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 172, 222, 228, 256, 288, 331 💬
2Bortezomib accord
(D03150)		[2] Bortezomib,
Bortezomib D-mannitol		[1] Bortezomib (D03150) 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
3Bortezomib D-mannitol
(D03150)		[2] Bortezomib,
Bortezomib D-mannitol		[1] Bortezomib (D03150) 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
4Bortezomib injection
(D03150)		[1] Bortezomib[1] Bortezomib (D03150) 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 64 💬
5Bortezomib/dexamethasone
(D03150)		[1] Bortezomib[1] Bortezomib (D03150) 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 283 💬
6Bortezomib/dexamethasone (BD), followed BY autologous STC & maintenance bortezomib/dexamethasone
(D03150)		[1] Bortezomib[1] Bortezomib (D03150) 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
7Combination OF A single dose ANTI-CD20 antibody and bortezomib
(D03150)		----[1] 61 💬
8Cyclophosphamide, bortezomib, and dexamethasone (cybord) regimen
(D03150)		[1] Cyclophosphamide[2] Cyclophosphamide ,
Cyclophosphamide 💬 		--[1] 28 💬
9Live combined bacillus subtilis and enterococcus faecium enteric-coated capsules combined with bortezomib+dexamethasone/bortezomib+dexamethasone+daratumumab/single daratumumab
(D03150)		[3] Bortezomib,
Daratumumab,
Dexamethasone		[5] Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib (D03150),
Dexamethasone phosphate ,
Daratumumab 💬 		[3] CD38,
NR3C1,
PSMB5 💬 		[15] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬[1] 28 💬